Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Subscribe To Our Newsletter & Stay Updated